Home Cart Sign in  
Chemical Structure| 76822-21-4 Chemical Structure| 76822-21-4

Structure of Danshensu
CAS No.: 76822-21-4

Chemical Structure| 76822-21-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Danshensu, a herbal preparation used in traditional Chinese medicine, possesses potential antitumor and antiangiogenesis effects.

Synonyms: Salvianic acid A; Dan shen suan A

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Danshensu

CAS No. :76822-21-4
Formula : C9H10O5
M.W : 198.17
SMILES Code : O=C(O)[C@H](O)CC1=CC=C(O)C(O)=C1
Synonyms :
Salvianic acid A; Dan shen suan A
MDL No. :MFCD09038703
InChI Key :PAFLSMZLRSPALU-MRVPVSSYSA-N
Pubchem ID :11600642

Safety of Danshensu

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H332-H335
Precautionary Statements:P261-P280-P305+P351+P338

Isoform Comparison

Biological Activity

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c mice SARS-CoV-2 S protein-induced acute lung inflammation model Intravenous injection 25, 50, 100 mg/kg Single intravenous injection Evaluate the protective effect of Danshensu on SARS-CoV-2 S protein-induced acute lung inflammation, results showed Danshensu dose-dependently alleviated pathological changes and inflammatory responses PMC8280584
BALB/c mice SARS-CoV-2 S protein-induced acute lung inflammation model Oral administration 25, 50, 100 mg/kg Oral administration for 7 days Evaluate the protective effect of Danshensu on SARS-CoV-2 S protein-induced acute lung inflammation, results showed Danshensu dose-dependently alleviated pathological changes and inflammatory responses PMC8280584

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

5.05mL

1.01mL

0.50mL

25.23mL

5.05mL

2.52mL

50.46mL

10.09mL

5.05mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories